S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 24 of 24

Issue Date	Title / Author(s) / Citation	File
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2015-01	TGF-β suppresses COX-2 expression by tristetraprolin-mediated RNA destabilization in A549 human lung cancer cells Kang, Soyeong; Min, Ahrum; Im, Seock-Ah; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Hyun-Ah; Kim, Hee-Jun; Oh, Do-Youn; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.1, pp.101-109	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Bang, Yung-Jue Breast Cancer Research, Vol.17, p. 33	view file DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O’Connor, Mark J O'Connor; Bang, Yung-Jue Breast Cancer Research, 17(1):33	view file DOI
2016-04	A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09 Lee, Ki Hyeong; Kim, Ji-Yeon; Lee, Moon Hee; Han, Hye Sook; Lim, Joo Han; Park, Keon Uk; Park, In Hae; Cho, Eun Kyung; Yoon, So Young; Kim, Jee Hyun; Choi, In Sil; Park, Jae Hoo; Choi, Young Jin; Kim, Hee-Jun; Jung, Kyung Hae; Kim, Si-Young; Oh, Do-Youn; Im, Seock-Ah Supportive Care in Cancer, Vol.24 No.4, pp.1709-1717	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-12	Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) Sim, Sung Hoon; Park, In Hae; Jung, Kyung Hae; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Kyung-Hun; Im, Seock-Ah; Im, Young-Hyuck; Park, Yeon Hee; Sohn, Joohyuk; Kim, Yu Jung; Lee, Suee; Kim, Hee-Jun; Chae, Yee Soo; Park, Kyong Hwa; Nam, Byung-Ho; Lee, Keun Seok; Ro, Jungsil British Journal of Cancer, Vol.121 No.12, pp.985-990	DOI
2019-12	Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): A multicentre, open-label, randomised, phase 2 trial Park, Yeon Hee; Kim, Tae-Yong; Kim, Gun Min; Kang, Seok Yun; Park, In Hae; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee-Jun; Kim, Han Jo; Lee, Jong In; Koh, Su-Jin; Kim, Ji-Yeon; Lee, Kyung-Hun; Sohn, Joohyuk; Kim, Sung-Bae; Ahn, Jin-Seok; Im, Young-Hyuck; Jung, Kyung Hae; Im, Seock-Ah The Lancet Oncology, Vol.20 No.12, pp.1750-1759	DOI
2020-02	Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12) Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Choi, Doo Ho; Park, Yeon Hee; Kim, Dae Yong; Kim, Tae Hyun; Choi, Byung Ock; Lee, Sea-Won; Kim, Suzy; Kwon, Jeanny; Kang, Ki Mun; Chung, Woong-Ki; Kim, Kyung Su; Nam, Ji Ho; Yoon, Won Sup; Kim, Jin Hee; Cha, Jihye; Oh, Yoon Kyeong; Kim, In Ah Breast, Vol.49, pp.41-47	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-06	Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer Ha, Dong-Hyeon; Min, Ahrum; Kim, Seongyeong; Jang, Hyemin; Kim, So Hyeon; Kim, Hee-Jun; Ryu, Han Suk; Ku, Ja-Lok; Lee, Kyung-Hun; Im, Seock-Ah Scientific Reports, Vol.10 No.1, p. 9930	DOI
2020-11	Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) Lee, Soohyeon; Im, Seock-Ah; Kim, Gun Min; Jung, Kyung Hae; Kang, Seok Yun; Park, In Hae; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee-Jun; Kim, Han Jo; Lee, Jong In; Koh, Su-Jin; Park, Yeon Hee Cancers, Vol.12 No.11, pp.3265-12	DOI
2021-04	New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12) Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Kim, Jee Hyun; Choi, Doo Ho; Park, Yeon Hee; Kim, Dae Yong; Kim, Tae Hyun; Choi, Byung Ock; Lee, Sea-Won; Kim, Suzy; Kwon, Jeanny; Kang, Ki Mun; Chung, Woong-Ki; Kim, Kyung Su; Yoon, Won Sup; Kim, Jin Hee; Cha, Jihye; Oh, Yoon Kyeong; Kim, In Ah Breast Cancer Research and Treatment, Vol.186 No.2, pp.453-462	DOI
2022-10	The Pattern of Care for Brain Metastasis from Breast Cancer Over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12) Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Kim, Jee Hyun; Choi, Doo Ho; Park, Yeon Hee; Kim, Dae Young; Kim, Tae Hyun; Choi, Byung Ock; Lee, Sea-Won; Kim, Suzy; Kwon, Jeanny; Kang, Ki Mun; Chung, Woong-Ki; Kim, Kyung Su; Nam, Ji Ho; Yoon, Won Sup; Kim, Jin Hee; Cha, Jihye; Oh, Yoon Kyeong; Kim, In Ah Cancer Research and Treatment, Vol.54 No.4, pp.1121-1129	DOI
2023-07	Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12) Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Kim, Jee Hyun; Choi, Doo Ho; Park, Yeon Hee; Kim, Dae Yong; Kim, Tae Hyun; Choi, Byung Ock; Lee, Sea-Won; Kim, Suzy; Kwon, Jeanny; Kang, Ki Mun; Chung, Woong-Ki; Kim, Kyung Su; Yoon, Won Sup; Kim, Jin Hee; Cha, Jihye; Oh, Yoon Kyeong; Kim, In Ah Breast Cancer Research and Treatment, Vol.200 No.1, pp.37-45	DOI
2023-12	Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Kim, Se Hyun; Im, Seock-Ah; Suh, Koung Jin; Lee, Kyung-Hun; Kim, Min Hwan; Sohn, Joohyuk; Park, Yeon Hee; Kim, Ji-Yeon; Jeong, Jae Ho; Lee, Kyoung Eun; Choi, In Sil; Park, Kyong Hwa; Kim, Hee-Jun; Cho, Eun Kyung; Park, So Yeon; Kim, Milim; Kim, Jee Hyun European Journal of Cancer, Vol.195, p. 113386	DOI
2024-01	Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial Lee, Dae-Won; Jung, Kyung Hae; Lee, Kyung-Hun; Park, Yeon Hee; Lee, Keun Seok; Sohn, Joohyuk; Ahn, Hee Kyung; Jeong, Jae Ho; Koh, Su-Jin; Kim, Jee Hyun; Kim, Han Jo; Lee, Kyoung Eun; Kim, Hee-Jun; Yang, Yae-Won; Park, Kyong Hwa; Lee, Jieun; Won, Hye Sung; Kim, Tae-Yong; Im, Seock-Ah European Journal of Cancer, Vol.197, p. 113456	DOI